We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$25.3M
Cap. Flow
-$29M
Cap. Flow %
-4.96%
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$3.6M
2
NVDA icon
NVIDIA
NVDA
+$1.81M
3
NTRA icon
Natera
NTRA
+$1.51M
4
PFE icon
Pfizer
PFE
+$1.41M
5
S icon
SentinelOne
S
+$706K

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.86M
2
MSFT icon
Microsoft
MSFT
+$2.82M
3
MA icon
Mastercard
MA
+$2.78M
4
CMCSA icon
Comcast
CMCSA
+$2.56M
5
AAPL icon
Apple
AAPL
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 35%
2 Healthcare 14.27%
3 Consumer Discretionary 13.55%
4 Communication Services 11.79%
5 Financials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOC icon
251
Healthpeak Properties
DOC
$15.1B
$70K 0.01%
1,929
– –
PPL
252
PPL Corp
PPL
$26.5B
$65K 0.01%
2,136
– –
COF icon
253
Capital One
COF
$128B
$64K 0.01%
444
– –
JCI icon
254
Johnson Controls International
JCI
$88.8B
$64K 0.01%
786
– –
WMB icon
255
Williams Companies
WMB
$87.5B
$64K 0.01%
2,458
– –
PBCT
256
DELISTED
People's United Financial Inc
PBCT
$64K 0.01%
3,596
– –
PGR icon
257
Progressive
PGR
$123B
$63K 0.01%
615
– –
HPE icon
258
Hewlett Packard
HPE
$63.4B
$62K 0.01%
3,879
– –
MRSH
259
Marsh
MRSH
$90.5B
$62K 0.01%
358
– –
COP icon
260
ConocoPhillips
COP
$147B
$61K 0.01%
842
– –
IVZ icon
261
Invesco
IVZ
$13.1B
$61K 0.01%
2,649
– –
MCO icon
262
Moody's
MCO
$82.8B
$61K 0.01%
157
– –
PEG icon
263
Public Service Enterprise Group
PEG
$38.2B
$61K 0.01%
910
– –
AMCR icon
264
Amcor
AMCR
$20.8B
$60K 0.01%
1,004
– –
GD icon
265
General Dynamics
GD
$104B
$57K 0.01%
274
– –
OXY icon
266
Occidental Petroleum
OXY
$56.8B
$55K 0.01%
1,904
– –
CTVA icon
267
Corteva
CTVA
$52.6B
$54K 0.01%
1,138
– –
HRB icon
268
H&R Block
HRB
$5.58B
$53K 0.01%
2,232
– –
NKTX icon
269
Nkarta
NKTX
$150M
$53K 0.01%
3,423
-220
-6% -$3.77K
TAP icon
270
Molson Coors Class B
TAP
$7.79B
$53K 0.01%
1,150
– –
EQIX icon
271
Equinix
EQIX
$101B
$51K 0.01%
60
– –
GIS icon
272
General Mills
GIS
$19.1B
$50K 0.01%
748
– –
CAH icon
273
Cardinal Health
CAH
$53.9B
$49K 0.01%
939
– –
WU icon
274
Western Union
WU
$1.98B
$49K 0.01%
2,743
– –
WRK
275
DELISTED
WestRock Company
WRK
$49K 0.01%
1,102
– –
9 10
11
12 13

Similar funds

NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Silvant Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.

  • Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
  • Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
  • Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
  • Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
  • Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
  • Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
  • Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.

Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.